Financials Trupanion, Inc.

Equities

TRUP

US8982021060

Life & Health Insurance

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
24.12 USD +3.47% Intraday chart for Trupanion, Inc. +7.44% -20.94%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,309 4,694 5,330 1,943 1,268 1,013 - -
Enterprise Value (EV) 1 1,309 4,694 5,330 1,943 1,268 1,013 1,013 1,013
P/E ratio -749 x -748 x -148 x -43.2 x -28.3 x -53.6 x 439 x 329 x
Yield - - - - - - - -
Capitalization / Revenue 3.41 x 9.35 x 7.62 x 2.15 x 1.14 x 0.81 x 0.74 x 0.69 x
EV / Revenue 3.41 x 9.35 x 7.62 x 2.15 x 1.14 x 0.81 x 0.74 x 0.69 x
EV / EBITDA 124 x 408 x 1,126 x 2,615 x 197 x 34.5 x 20.4 x 16.8 x
EV / FCF 121 x - -1,088 x -77.5 x 3,541 x 25.6 x 15.3 x 9.8 x
FCF Yield 0.82% - -0.09% -1.29% 0.03% 3.9% 6.52% 10.2%
Price to Book - - 16.1 x 6.55 x 4.16 x 3.45 x 3.32 x 3.8 x
Nbr of stocks (in thousands) 34,947 39,215 40,368 40,884 41,545 41,995 - -
Reference price 2 37.46 119.7 132.0 47.53 30.51 24.12 24.12 24.12
Announcement Date 2/13/20 2/10/21 2/16/22 2/15/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 383.9 502 699 905.2 1,109 1,256 1,377 1,471
EBITDA 1 10.58 11.51 4.734 0.743 6.434 29.35 49.72 60.45
EBIT 1 -1.92 -4.927 -35.2 -43 -40.66 -14.59 4.51 9.567
Operating Margin -0.5% -0.98% -5.04% -4.75% -3.67% -1.16% 0.33% 0.65%
Earnings before Tax (EBT) 1 -1.64 -5.727 -35.22 -44.2 -45.04 -19.09 3.865 3.567
Net income 1 -1.809 -5.84 -35.53 -44.67 -44.69 -18.98 2.451 3.2
Net margin -0.47% -1.16% -5.08% -4.94% -4.03% -1.51% 0.18% 0.22%
EPS 2 -0.0500 -0.1600 -0.8900 -1.100 -1.080 -0.4500 0.0550 0.0733
Free Cash Flow 1 10.78 - -4.897 -25.09 0.358 39.5 66.01 103.4
FCF margin 2.81% - -0.7% -2.77% 0.03% 3.15% 4.79% 7.03%
FCF Conversion (EBITDA) 101.91% - - - 5.56% 134.59% 132.76% 171%
FCF Conversion (Net income) - - - - - - 2,693.53% 3,230.22%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/13/20 2/10/21 2/16/22 2/15/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 181.7 194.4 206 219.4 233.8 246 256.3 270.6 285.9 295.9 300.6 308.1 318.9 328 331
EBITDA 1 2.17 3.499 1.178 -1.666 -0.943 2.175 -4.869 -3.242 6.058 8.487 4.461 5.639 7.801 11.43 10.42
EBIT 1 -7.192 -5.763 -9.114 -12.77 -11.9 -9.217 -24.49 -13.09 -3.491 0.408 -6.816 -5.247 -2.832 0.3025 -1.097
Operating Margin -3.96% -2.96% -4.42% -5.82% -5.09% -3.75% -9.55% -4.84% -1.22% 0.14% -2.27% -1.7% -0.89% 0.09% -0.33%
Earnings before Tax (EBT) 1 -7.131 -6.008 -8.879 -13.6 -12.42 -9.3 -24.97 -13.95 -4.079 -2.033 -8.512 -6.791 -4.533 -1.438 -4.406
Net income 1 -6.819 -7.042 -8.855 -13.62 -12.91 -9.285 -24.78 -13.71 -4.036 -2.163 -8.166 -6.233 -3.713 -0.7255 -4.034
Net margin -3.75% -3.62% -4.3% -6.21% -5.52% -3.77% -9.67% -5.07% -1.41% -0.73% -2.72% -2.02% -1.16% -0.22% -1.22%
EPS 2 -0.1700 -0.1700 -0.2200 -0.3300 -0.3200 -0.2300 -0.6000 -0.3300 -0.1000 -0.0500 -0.1986 -0.1500 -0.0857 -0.0200 -0.0550
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/3/21 2/16/22 4/28/22 8/3/22 11/3/22 2/15/23 5/4/23 8/3/23 11/2/23 2/15/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 10.8 - -4.9 -25.1 0.36 39.5 66 103
ROE (net income / shareholders' equity) - - -10.6% - - - - -
ROA (Net income/ Total Assets) - - -6.7% - - - - -
Assets 1 - - 530.4 - - - - -
Book Value Per Share 2 - - 8.210 7.260 7.330 7.000 7.270 6.340
Cash Flow per Share - - - - - - - -
Capex 5.37 - 12.4 17.1 - - - -
Capex / Sales 1.4% - 1.77% 1.89% - - - -
Announcement Date 2/13/20 2/10/21 2/16/22 2/15/23 2/15/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
24.12 USD
Average target price
35.67 USD
Spread / Average Target
+47.87%
Consensus
  1. Stock Market
  2. Equities
  3. TRUP Stock
  4. Financials Trupanion, Inc.